-
★
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19
(Hinzugefügt: 05.03.2021 um 07:18 Uhr)
https://jamanetwork.com/journals/jama/fullarticle/2777389?utm_source=twitter&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=030421#.YEENJMwggDY.twitter
-
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial
(Hinzugefügt: 05.08.2023 um 15:30 Uhr)
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00299-2/fulltext
-
COVID-19: Ivermectin bleibt auch in US-Studie ohne relevante Wirkung
(Hinzugefügt: 24.06.2022 um 09:11 Uhr)
https://www.aerzteblatt.de/nachrichten/135034/COVID-19-Ivermectin-bleibt-auch-in-US-Studie-ohne-relevante-Wirkung
-
Safety and Efficacy of Ivermectin for the Prevention and Treatment of COVID-19: A Double-Blinded Randomized Placebo-Controlled Study
(Hinzugefügt: 24.06.2022 um 09:05 Uhr)
https://www.mdpi.com/2079-6382/11/6/796
-
IVERMECTIN NO LONGER ALLOWED TO TREAT COVID-19 IN SOUTH AFRICA
(Hinzugefügt: 06.06.2022 um 09:11 Uhr)
https://ewn.co.za/2022/05/30/ivermectin-no-longer-allowed-to-treat-covid-19-in-south-africa
-
Effect of Early Treatment with Ivermectin among Patients with Covid-19
(Hinzugefügt: 03.04.2022 um 18:07 Uhr)
https://www.nejm.org/doi/full/10.1056/NEJMoa2115869
-
Comparison of Trials Using Ivermectin for COVID-19 Between Regions With High and Low Prevalence of Strongyloidiasis
(Hinzugefügt: 22.03.2022 um 11:32 Uhr)
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2790173
-
Treatment with Ivermectin Is Associated with Decreased Mortality in COVID-19 Patients: Analysis of a National Federated Database
(Hinzugefügt: 06.03.2022 um 18:34 Uhr)
https://www.sciencedirect.com/science/article/pii/S1201971221009887
-
Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities
(Hinzugefügt: 19.02.2022 um 13:17 Uhr)
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2789362
-
Once again: Ivermectin (DRIPONIN and others) against COVID-19?
(Hinzugefügt: 10.01.2022 um 12:42 Uhr)
https://www.arznei-telegramm.de/html/2021_12/2112812_01.html
-
Nochmals: Ivermectin (DRIPONIN u.a.) gegen COVID-19?
(Hinzugefügt: 21.12.2021 um 13:00 Uhr)
https://www.arznei-telegramm.de/html/2021_12/2112423_01.html
-
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines
(Hinzugefügt: 13.12.2021 um 10:43 Uhr)
https://journals.lww.com/americantherapeutics/fulltext/2021/08000/ivermectin_for_prevention_and_treatment_of.7.aspx
-
Ivermectin for COVID-19: addressing potential bias and medical fraud
(Hinzugefügt: 29.10.2021 um 13:44 Uhr)
https://www.researchsquare.com/article/rs-1003006/v1
-
SARS-CoV-2: Behandlungsversuch mit Ivermectin kann toxisch sein
(Hinzugefügt: 22.10.2021 um 16:20 Uhr)
https://www.aerzteblatt.de/nachrichten/128376/SARS-CoV-2-Behandlungsversuch-mit-Ivermectin-kann-toxisch-sein
-
Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19
(Hinzugefügt: 22.10.2021 um 16:19 Uhr)
https://www.nejm.org/doi/full/10.1056/NEJMc2114907
-
The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable
(Hinzugefügt: 23.09.2021 um 10:11 Uhr)
https://www.nature.com/articles/s41591-021-01535-y
-
Bayesian Hypothesis Testing and Hierarchical Modeling of Ivermectin Effectiveness
(Hinzugefügt: 19.09.2021 um 14:44 Uhr)
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8415515/
-
Rapid Increase in Ivermectin Prescriptions and Reports of Severe Illness Associated with Use of Products Containing Ivermectin to Prevent or Treat COVID-19
(Hinzugefügt: 28.08.2021 um 13:50 Uhr)
https://emergency.cdc.gov/han/2021/pdf/CDC_HAN_449.pdf?mc_cid=e38f915a98&mc_eid=f534d23cf9
-
Kein Beleg für Nutzen von Parasitenmedikament Ivermectin bei COVID-19
(Hinzugefügt: 14.08.2021 um 08:48 Uhr)
https://www.aerzteblatt.de/nachrichten/126345/Kein-Beleg-fuer-Nutzen-von-Parasitenmedikament-Ivermectin-bei-COVID-19
-
Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection
(Hinzugefügt: 13.07.2021 um 06:51 Uhr)
https://rcm.imrpress.com/article/2020/2153-8174/RCM2020260.shtml
-
Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection
(Hinzugefügt: 09.07.2021 um 18:55 Uhr)
https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofab358/6316214
-
Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial
(Hinzugefügt: 05.07.2021 um 11:27 Uhr)
https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-021-06348-5
-
Study of the Efficacy and Safety of Topical Ivermectin + Iota- Carrageenan in the Prophylaxis against COVID-19 in Health Personnel
(Hinzugefügt: 30.06.2021 um 15:29 Uhr)
https://www.researchgate.net/publication/346034534_Study_of_the_Efficacy_and_Safety_of_Topical_Ivermectin_Iota-_Carrageenan_in_the_Prophylaxis_against_COVID-19_in_Health_Personnel
-
The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article
(Hinzugefügt: 20.06.2021 um 17:52 Uhr)
https://www.nature.com/articles/s41429-021-00430-5
-
Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial
(Hinzugefügt: 20.06.2021 um 17:15 Uhr)
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00239-X/fulltext
-
Ivermectin for Prevention and Treatment of COVID-19 Infection
(Hinzugefügt: 20.06.2021 um 17:13 Uhr)
https://journals.lww.com/americantherapeutics/Abstract/9000/Ivermectin_for_Prevention_and_Treatment_of.98040.aspx
-
Ivermectin As a COVID-19 Therapy
(Hinzugefügt: 09.06.2021 um 19:32 Uhr)
https://blogs.sciencemag.org/pipeline/archives/2021/06/07/ivermectin-as-a-covid-19-therapy
-
Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial
(Hinzugefügt: 16.05.2021 um 10:14 Uhr)
https://journals.sagepub.com/doi/10.1177/03000605211013550
-
Ivermectin and the odds of hospitalization due to COVID-19: evidence from a quasi-experimental analysis based on a public intervention in Mexico City
(Hinzugefügt: 11.05.2021 um 07:07 Uhr)
https://osf.io/preprints/socarxiv/r93g4/
-
Effect of ivermectin on COVID-19: A multicenter double-blind randomized controlled clinical trial
(Hinzugefügt: 09.05.2021 um 14:13 Uhr)
https://www.sciencedirect.com/science/article/pii/S0149291821002010
-
Repurposing Ivermectin for COVID-19: Molecular Aspects and Therapeutic Possibilities
(Hinzugefügt: 30.03.2021 um 19:37 Uhr)
https://www.frontiersin.org/articles/10.3389/fimmu.2021.663586/full
-
Global trends in clinical studies of ivermectin in COVID-19
(Hinzugefügt: 26.03.2021 um 20:58 Uhr)
http://jja-contents.wdc-jp.com/pdf/JJA74/74-1-open/74-1_44-95.pdf
-
Ivermectin for prevention and treatment of COVID-19 infection: a systematic review and meta-analysis
(Hinzugefügt: 12.03.2021 um 05:39 Uhr)
https://osf.io/k37ft/
-
Phase 2 randomized study on chloroquine, hydroxychloroquine or ivermectin in hospitalized patients with severe manifestations of SARS-CoV-2 infection
(Hinzugefügt: 11.03.2021 um 09:02 Uhr)
https://www.tandfonline.com/doi/full/10.1080/20477724.2021.1890887
-
Use of ivermectin in the treatment of Covid-19: a pilot trial
(Hinzugefügt: 10.03.2021 um 08:12 Uhr)
https://www.sciencedirect.com/science/article/pii/S2214750021000445
-
FAQ: COVID-19 and Ivermectin Intended for Animals
(Hinzugefügt: 09.03.2021 um 13:17 Uhr)
https://www.fda.gov/animal-veterinary/product-safety-information/faq-covid-19-and-ivermectin-intended-animals
-
Is Ivermectin Approved for Coronavirus? Clinical Trials Reveal Antiparasite Drug Does Not Alleviate COVID-19 Symptoms
(Hinzugefügt: 07.03.2021 um 08:19 Uhr)
https://www.sciencetimes.com/articles/30017/20210306/ivermectin-approved-coronavirus-clinical-trials-reveal-antiparasite-drug-alleviate-covid.htm
-
COVID-19: Ivermectin scheitert in klinischer Studie in Lateinamerika
(Hinzugefügt: 06.03.2021 um 08:08 Uhr)
https://www.aerzteblatt.de/nachrichten/121789/COVID-19-Ivermectin-scheitert-in-klinischer-Studie-in-Lateinamerika
-
The Binding mechanism of Ivermectin and levosalbutamol with spike protein of SARS-CoV-2
(Hinzugefügt: 03.03.2021 um 08:35 Uhr)
https://www.researchsquare.com/article/rs-160254/v1
-
Evaluation of the Effectiveness and Safety of Adding Ivermectin to Treatment in Severe COVID-19 Patients
(Hinzugefügt: 25.02.2021 um 20:06 Uhr)
https://www.researchsquare.com/article/rs-224203/v1
-
Ivermectin shows clinical benefits in mild to moderate COVID19: A randomised controlled double-blind, dose-response study in Lagos
(Hinzugefügt: 19.02.2021 um 10:28 Uhr)
https://academic.oup.com/qjmed/advance-article/doi/10.1093/qjmed/hcab035/6143037
-
Effect of a combination of Nitazoxanide, Ribavirin and Ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID‐19
(Hinzugefügt: 17.02.2021 um 14:49 Uhr)
https://onlinelibrary.wiley.com/doi/10.1002/jmv.26880
-
Role of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: A matched case-control study
(Hinzugefügt: 17.02.2021 um 14:47 Uhr)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0247163
-
Ivermectin (DRIPONIN) gegen COVID-19?
(Hinzugefügt: 17.02.2021 um 08:46 Uhr)
https://www.arznei-telegramm.de/html/2021_01/2101006_02.html
-
Merck Statement on Ivermectin use During the COVID-19 Pandemic
(Hinzugefügt: 05.02.2021 um 08:26 Uhr)
https://www.merck.com/news/merck-statement-on-ivermectin-use-during-the-covid-19-pandemic/
-
Is ivermectin ready to be part of a public health policy for COVID-19 prophylaxis?
(Hinzugefügt: 05.02.2021 um 08:14 Uhr)
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00024-9/fulltext?rss=yes
-
Sharp Reductions in COVID-19 Case Fatalities and Excess Deaths in Peru in Close Time Conjunction, State-By-State, with Ivermectin Treatments
(Hinzugefügt: 30.01.2021 um 11:30 Uhr)
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3765018
-
Outcomes of Ivermectin in the treatment of COVID-19: a systematic review and meta-analysis
(Hinzugefügt: 27.01.2021 um 17:56 Uhr)
https://www.medrxiv.org/content/10.1101/2021.01.26.21250420v1
-
Ivermectin for Severe COVID-19 Management
(Hinzugefügt: 27.01.2021 um 17:56 Uhr)
https://clinicaltrials.gov/ct2/show/results/NCT04646109?view=results
-
Use of Ivermectin as a Potential Chemoprophylaxis for COVID-19 in Egypt: A Randomised Clinical Trial
(Hinzugefügt: 26.01.2021 um 12:52 Uhr)
https://www.researchgate.net/publication/348755915_Use_of_Ivermectin_as_a_potential_chemoprophylaxis_for_COVID-19_in_Egypt_A_Randomised_clinical_trial
-
Ivermectin (DRIPONIN) gegen COVID-19?
(Hinzugefügt: 22.01.2021 um 19:15 Uhr)
https://www.arznei-telegramm.de/html/2021_01/2101006_02.html
-
Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection
(Hinzugefügt: 20.01.2021 um 09:05 Uhr)
https://www.researchsquare.com/article/rs-148845/v1
-
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial
(Hinzugefügt: 20.01.2021 um 09:03 Uhr)
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30464-8/fulltext
-
FLCCC Alliance Response to the NIH Guideline Committee Recommendation on Ivermectin use in COVID-19 dated January 14th , 2021
(Hinzugefügt: 20.01.2021 um 08:46 Uhr)
https://covid19criticalcare.com/wp-content/uploads/2021/01/FLCCC-Alliance-Response-to-the-NIH-Guideline-Committee-Recommendation-on-Ivermectin-use-in-COVID19-2021-01-18.pdf
-
Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan (Ivercar-Tuc)
(Hinzugefügt: 18.01.2021 um 21:08 Uhr)
https://clinicaltrials.gov/ct2/show/NCT04701710
-
New York Supreme Court Judge Order: Give The Patient Ivermectin As Court Battle Leads to Ivermectin for Successful Treatment Against COVID-19
(Hinzugefügt: 17.01.2021 um 07:31 Uhr)
https://trialsitenews.com/new-york-supreme-court-judge-order-give-the-patient-ivermectin-as-court-battle-leads-to-ivermectin-for-successful-treatment-against-covid-19/
-
The COVID-19 Treatment Guidelines Panel’s Statement on the Use of Ivermectin for the Treatment of COVID-19
(Hinzugefügt: 16.01.2021 um 08:33 Uhr)
https://www.covid19treatmentguidelines.nih.gov/statement-on-ivermectin/
-
A systematic review of experimental evidence for antiviral effects of ivermectin and an in‐silico analysis of ivermectin's possible mode of action against SARS‐CoV‐2
(Hinzugefügt: 14.01.2021 um 08:52 Uhr)
https://onlinelibrary.wiley.com/doi/abs/10.1111/fcp.12644
-
Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
(Hinzugefügt: 13.01.2021 um 19:29 Uhr)
https://www.frontiersin.org/articles/10.3389/fphar.2021.643369/abstract
-
SAHPRA’S GUIDANCE ON THE USE OF IVERMECTIN IN THE PROPHYLAXIS OR TREATMENT OF COVID-19
(Hinzugefügt: 11.01.2021 um 19:02 Uhr)
https://www.sahpra.org.za/news-and-updates/sahpras-guidance-on-the-use-of-ivermectin-in-the-prophylaxis-or-treatment-of-covid-19/
-
Ivermectin as a potential treatment for mild to moderate COVID-19 – A double blind randomized placebo-controlled trial
(Hinzugefügt: 11.01.2021 um 18:59 Uhr)
https://www.medrxiv.org/content/10.1101/2021.01.05.21249310v1
-
Ivermectin as Prophylaxis Against COVID-19 Retrospective Cases Evaluation
(Hinzugefügt: 07.01.2021 um 05:06 Uhr)
https://scivisionpub.com/pdfs/ivermectin-as-prophylaxis-against-covid19-retrospective-cases-evaluation-1458.pdf
-
Ivermectin reduces the risk of death from COVID-19 -a rapid review and meta-analysis in support of the recommendation of the Front Line COVID-19 Critical Care Alliance.
(Hinzugefügt: 05.01.2021 um 17:52 Uhr)
https://www.researchgate.net/publication/348230894_Ivermectin_reduces_the_risk_of_death_from_COVID-19_-a_rapid_review_and_meta-analysis_in_support_of_the_recommendation_of_the_Front_Line_COVID-19_Critical_Care_Alliance
-
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
(Hinzugefügt: 16.12.2020 um 19:02 Uhr)
https://osf.io/wx3zn/
-
Ivermectin Use Associated with Reduced Duration of COVID-19 Febrile Illness in a Community Setting
(Hinzugefügt: 16.12.2020 um 19:00 Uhr)
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3734478
-
Ivermectin as Pre-exposure Prophylaxis for COVID-19 among Healthcare Providers in a Selected Tertiary Hospital in Dhaka –An Observational Study
(Hinzugefügt: 16.12.2020 um 18:55 Uhr)
https://www.ejmed.org/index.php/ejmed/article/view/599/337?fbclid=IwAR10MWtbUR4Nn5J05Xlce8eSTyFT8zxdxouZSokAAZjvgYYVMOnlyAxRW-M
-
Antiviral and Anti-Inflammatory Properties of Ivermectin and Its Potential Use in COVID-19
(Hinzugefügt: 11.12.2020 um 07:58 Uhr)
https://www.sciencedirect.com/science/article/pii/S030028962030212X
-
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro Author links open overlay panel
(Hinzugefügt: 11.12.2020 um 07:43 Uhr)
https://www.sciencedirect.com/science/article/pii/S0166354220302011
-
Ivermectin (Oral Route)
(Hinzugefügt: 10.12.2020 um 12:27 Uhr)
https://www.mayoclinic.org/drugs-supplements/ivermectin-oral-route/proper-use/drg-20064397
-
A five day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness
(Hinzugefügt: 10.12.2020 um 12:27 Uhr)
https://www.ijidonline.com/article/S1201-9712(20)32506-6/fulltext